Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.
Intravaginal drug delivery systems are engineered to provide sustained release of hormonal agents. These include matrix diffusion-controlled devices, such as those incorporating medroxyprogesterone acetate within a silicone elastomer, and dissolution-controlled systems where progestins and estrogens are dispersed in a polyethylene glycol (PEG) and silicone matrix. A common formulation is the vaginal ring, which is manufactured via extrusion of the drug-silicone composition into a doughnut-shaped device. These rings typically release hormones for approximately 21 days, maintaining a cyclic hormonal profile for contraceptive efficacy.
Intrauterine delivery systems are designed for extended contraceptive effectiveness, typically exceeding 12 months. Two primary types of medicated IUDs are widely utilized:
These controlled-release systems exemplify the integration of pharmaceutical technology with reproductive healthcare, offering both short- and long-term contraceptive options.
Intravaginal drug delivery systems bypass first-pass metabolism, enhancing bioavailability and often making them more efficient than oral administration.
These systems include matrix diffusion-controlled devices, like medroxyprogesterone acetate in silicone, and dissolution-controlled devices, using progestin and estrogen dispersion in PEG and silicone.
Such devices are often formulated as vaginal rings, which provide sustained hormone release for up to 21 days, offering a cyclic intravaginal contraception.
For long-term contraception, intrauterine devices or IUDs are commonly used as they remain effective for 12 months to several years, depending on the device type.
Copper IUDs, commonly T- or 7-shaped, gradually release copper ions that exert a localized contraceptive effect lasting over three years.
The progesterone-releasing IUD is also a T-shaped device that releases progesterone dispersed in a silicone polymer through a controlled membrane.
As a result, it provides a consistent hormone dose, offering effective contraception for up to one year.
繁體中文
